CUE BIOPHARMA INC. -
1.7900
07-November-24 14:38:17
15 minutes delayed
Stocks
+0.1400
+8.48%
Today's range
1.5900 - 1.9000
ISIN
N/A
Source
NASDAQ
-
16 Feb 2023 09:30:00 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board
16 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two February 2023 Scientific Conferences
01 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces Chief Medical Officer Transition
23 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
22 Nov 2022 07:00:04 By Nasdaq GlobeNewswire
-
Cue Biopharma Reports Third Quarter 2022 Financial Results
14 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
14 Nov 2022 07:20:14 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
09 Nov 2022 07:00:03 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
07 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
05 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
04 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two September 2022 Scientific Conferences
07 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
22 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma Reports Second Quarter 2022 Financial Results
04 Aug 2022 15:30:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
11 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the JMP Securities Life Sciences Conference
13 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Jefferies Healthcare Conference
01 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
26 May 2022 16:00:00 By Nasdaq GlobeNewswire
-
11 May 2022 07:01:12 By Nasdaq GlobeNewswire